|
Organ
|
Training data
|
Validation data
|
Test data
|
|---|
|
No.
|
%
|
Errors
|
%
|
No.
|
%
|
Errors
|
%
|
No.
|
%
|
Errors
|
%
|
|---|
|
Primary carcinoma
|
232
|
41.3%
|
42
|
18.1%
|
163
|
42.7%
|
25
|
15.3%
|
89
|
54.3%
|
7
|
7.9%
|
|
Metastatic carcinoma
|
151
|
26.9%
|
39
|
25.8%
|
98
|
25.7%
|
26
|
26.5%
|
19
|
11.6%
|
4
|
21.1%
|
|
Benign (normal) lesion
|
33
|
5.9%
|
4
|
12.1%
|
22
|
5.8%
|
3
|
13.6%
|
13
|
7.9%
|
1
|
7.7%
|
|
Benign mesenchymal tumor
|
120
|
21.4%
|
28
|
23.3%
|
80
|
20.9%
|
24
|
30.0%
|
24
|
14.6
|
4
|
16.7%
|
|
Malignant mesenchymal tumor
|
26
|
4.6%
|
8
|
30.8%
|
19
|
5.0%
|
6
|
31.6%
|
19
|
11.6%
|
2
|
10.5%
|
| |
562
|
100.0%
|
121
|
21.5%
|
382
|
100.0%
|
84
|
22.0%
|
164
|
100%
|
18
|
11%
|
- Abbreviations: TUO Tumor of unknown origin